Literature DB >> 25423403

The Production of Polyclonal Antibodies in Laboratory Animals. The Report and Recommendations of ECVAM Workshop 35.

P P Leenaars1, C F Hendriksen1, W A de Leeuw2, F Carat3, P Delahaut4, R Fischer5, M Halder6, W C Hanly7, J Hartinger8, J Hau9, E B Lindblad10, W Nicklas11, I M Outschoorn12, D E Stewart-Tull13.   

Abstract

This is the report of the thirty-fifth of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM's main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures which would enable it to become well informed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of various types of in vitro tests and their potential uses, and make recommendations about the best ways forward (1). This joint ECVAM/FELASA (Federation of European Laboratory Animal Science Associations) workshop on The Immunisation of Laboratory Animals for the Production of Polyclonal Antibodies was held in Utrecht (The Netherlands), on 20-22 March 1998, under the co-chairmanship of Coenraad Hendriksen (RIVM, Bilthoven, The Netherlands) and Wim de Leeuw (Inspectorate for Health Protection, The Netherlands). The participants, all experts in the fields of immunology, laboratory animal science, or regulation, came from universities, industry and regulatory bodies. The aims of the workshop were: a) to discuss and evaluate current immunisation procedures for the production of polyclonal antibodies (including route of injection, animal species and adjuvant ); and b) to draft recommendations and guidelines to improve the immunisation procedures, with regard both to animal welfare and to the optimisation of immunisation protocols. This report summarises the outcome of the discussions and includes a number of recommendations and a set of draft guidelines (included in Appendix 1). 1999 FRAME.

Entities:  

Year:  1999        PMID: 25423403     DOI: 10.1177/026119299902700106

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  6 in total

1.  Penaeus monodon thioredoxin restores the DNA binding activity of oxidized white spot syndrome virus IE1.

Authors:  Jiun-Yan Huang; Wang-Jing Liu; Han-Ching Wang; Der-Yen Lee; Jiann-Horng Leu; Hao-Ching Wang; Mong-Hsun Tsai; Shih-Ting Kang; I-Tung Chen; Guang-Hsiung Kou; Geen-Dong Chang; Chu-Fang Lo
Journal:  Antioxid Redox Signal       Date:  2012-04-16       Impact factor: 8.401

Review 2.  Reported analgesic administration to rabbits undergoing experimental surgical procedures.

Authors:  Claire A Coulter; Paul A Flecknell; Matthew C Leach; Claire A Richardson
Journal:  BMC Vet Res       Date:  2011-02-21       Impact factor: 2.741

Review 3.  Adjuvants: Classification, Modus Operandi, and Licensing.

Authors:  Juliana de Souza Apostólico; Victória Alves Santos Lunardelli; Fernanda Caroline Coirada; Silvia Beatriz Boscardin; Daniela Santoro Rosa
Journal:  J Immunol Res       Date:  2016-05-04       Impact factor: 4.818

4.  Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G.

Authors:  Hadi Nasiri; Zahra Valedkarimi; Leili Aghebati-Maleki; Jalal Abdolalizadeh; Tohid Kazemi; Mojghan Esparvarinha; Jafar Majidi
Journal:  Vet Res Forum       Date:  2017-12-15       Impact factor: 1.054

5.  Exploring the antigenic response to multiplexed immunizations in a chicken model of antibody production.

Authors:  Tina M Kousted; Otto Kalliokoski; Sofie K Christensen; Jakob R Winther; Jann Hau
Journal:  Heliyon       Date:  2017-03-16

6.  Development and statistical validation of a guinea pig model for vaccine potency testing against Infectious Bovine Rhinothracheitis (IBR) virus.

Authors:  Viviana Parreño; María Virginia López; Daniela Rodriguez; María Marta Vena; Mercedes Izuel; Jorge Filippi; Alejandra Romera; Claudia Faverin; Rodolfo Bellinzoni; Fernando Fernandez; Laura Marangunich
Journal:  Vaccine       Date:  2010-01-30       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.